about
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for au...
Read More
5.77
-0.04
(-0.69%)
996.5K
XNAS Volume
XNAS 12 Jan, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Savara Inc is on 14 Jan 2026 for the purpose of 44th Annual J.P. Morgan Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Bullish
Savara Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..